STUGERON

Found in: Cyprus Spain Lithuania Singapore United Kingdom

Active ingredients

#
Active Ingredient
Description
1

Cinnarizine has been shown to be a non-competitive antagonist of the smooth muscle contractions caused by various vasoactive agents including histamine. Cinnarizine also acts on vascular smooth muscle by selectively inhibiting the calcium influx into depolarised cells, thereby reducing the availability of free Ca2+ ions for the induction and maintenance of contraction.

Medicine classification

ATC Code
Title
Class
Cinnarizine
N Nervous system → N07 Other nervous system drugs → N07C Antivertigo preparations → N07CA Antivertigo preparations

Product monographs

Monograph
Type
Country
MPI, EU: SmPC
UK

Identifiers

Authority
Identifier(s)
Health Sciences Authority (SG)
Identifier(s): 01122P
Centro de información online de medicamentos de la AEMPS (ES)
Identifier(s): 53025
Medicines & Healthcare Products Regulatory Agency (GB)
Identifier(s): 121347, 15693
Valstybinė vaistų kontrolės tarnyba (LT)
Identifier(s): 1012300, 1012913, 1067512